Therapy Areas: Vaccines
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
7 November 2025 - PharmaJet®, a leader in needle-free drug delivery systems designed to improve outcomes and patient comfort, has confirmed a new Distribution Agreement with ATR, an affiliate comp...
Lunai Bioworks publishes breakthrough on second-generation allogeneic dendritic cell therapy in vaccines
5 November 2025 - Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefence company, on Wednesday announced the publication of a landmark study detailing its second-generation allogen...
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
3 November 2025 - Frontier IP Group plc (AIM: FIPP) announced on Monday that its portfolio company The Vaccine Group has achieved outstanding results in cattle challenge trials for two vaccine candida...
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
3 November 2025 - South Korean pharmaceutical company GC Biopharma (KRX:006280) announced on Monday that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' ...
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
31 October 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Friday it has been awarded a new and expanded procurement framework contract by the European Commission thr...
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
29 October 2025 - Animal health business Zoetis Inc (NYSE: ZTS) announced on Wednesday that the European Commission has granted marketing authorization for Portela (relfovetmab), the first monoclonal ...